Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Transfus Med ; 25(1): 33-7, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25683623

RESUMEN

OBJECTIVES: The study was designed to evaluate the effect of warfarin on perioperative transfusion, bleeding and coagulation status in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). BACKGROUND: There were controversy about the effect of warfarin on perioperative transfusion and bleeding. METHODS/MATERIALS: Medical records from 107 consecutive patients with atrial fibrillation (AF) on warfarin therapy undergoing cardiac surgery with cardiopulmonary bypass (CPB) from 2008 to 2013 at a single university teaching hospital were retrospectively reviewed to compare the patients on to those not on warfarin therapy in terms of perioperative transfusion requirement, postoperative 24-h bleeding amount, and coagulation status assessment using prothrombin time (PT), international normalised ratio (INR) and rotational thromboelastometry (ROTEM®). RESULTS: Although PT/INR was significantly prolonged both before and after surgery in patients on warfarin therapy, ROTEM® data, perioperative transfusion requirement and postoperative 24-h bleeding amount (785 ± 331 vs 676 ± 303 mL, P = 0·089, respectively) were not significantly different between the patients on and those not on warfarin therapy. CONCLUSION: In patients on warfarin therapy undergoing cardiac surgery with CPB, warfarin therapy did not significantly increase perioperative transfusion requirement and bleeding.


Asunto(s)
Anticoagulantes/administración & dosificación , Pérdida de Sangre Quirúrgica , Transfusión Sanguínea , Puente Cardiopulmonar , Atención Perioperativa , Warfarina/administración & dosificación , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
2.
Gene Ther ; 21(4): 353-62, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24500526

RESUMEN

Foam cell formation from macrophage is a major cause of atherosclerosis. An efficient macrophage-specific promoter is required for the targeting to macrophages. In this study, we develop a macrophage-specific synthetic promoter for the therapeutic application of adiponectin (APN), an antiatherogenic gene. Synthetic promoter-146 (SP146), registered on the NCBI website (http://www.ncbi.nlm.nih.gov/nuccore/DQ107383), was tested for promoter activities in two non-macrophage cell lines (293 T, HeLa) and a macrophage cell line (RAW264.7, bone marrow-derived macrophages). To enforce macrophage specificity, partial elements of p47(phox) including the PU.1 site with various lengths (-C1, -C2 and -C3) were inserted next to the synthetic promoters. SP146-C1 showed the highest specificity and efficacy in RAW264.7 cells and was selected for development of an APN-carrying macrophage-specific promoter. Green fluorescent protein (GFP)- or APN-expressing lentivirus under SP146-C1 (Lenti-SP-GFP or Lenti-SP-APN, respectively) showed the highest expression efficacy in RAW264.7 cells compared with the non-macrophage cell lines. APN overexpression in RAW264.7 cells successfully inhibited intracellular lipid accumulation, and atherosclerotic lesions and lipid accumulation were significantly reduced by Lenti-SP-APN in ApoE-/- atherosclerosis mice. In conclusion, the synthetic promoter SP146-C1, combined with a p47(phox) promoter element, was successfully developed to target macrophage, and macrophage-specific introduction of APN under SP146-C1 was shown to ameliorate the atherosclerotic pathology.


Asunto(s)
Adiponectina/genética , Aterosclerosis/genética , Terapia Genética , Regiones Promotoras Genéticas , Adiponectina/uso terapéutico , Animales , Aterosclerosis/patología , Aterosclerosis/terapia , Células Espumosas/metabolismo , Células Espumosas/patología , Células HeLa , Humanos , Lentivirus/genética , Macrófagos/metabolismo , Ratones , Datos de Secuencia Molecular
4.
J Laryngol Otol ; 137(6): 643-650, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-35968691

RESUMEN

OBJECTIVE: This study aimed to analyse surgical outcomes of paediatric patients with congenital cholesteatoma according to age. METHOD: This was a retrospective study reviewing the records of 186 children (136 boys and 50 girls) from August 1993 to January 2016. Patients were divided into three age groups (equal to or less than 3 years, over 3 and less than 7 years, and 7 to 15 years). RESULTS: There were significant differences in chief complaints, location of cholesteatoma in the middle ear, computed tomography findings, operation methods, ossicular erosion and type of cholesteatoma sac among the three groups. In addition, older age, open type cholesteatoma, ossicular erosion and mastoid invasion of cholesteatoma increased the recurrence rate after surgery. However, despite higher pre-operative air-bone gap in older children, hearing can be improved enough after proper surgery with ossicular reconstruction. CONCLUSION: Delayed detection of paediatric cholesteatoma can lead to extensive disease and the need for an aggressive operation, which can result in worse hearing outcomes and an increased recurrence risk.


Asunto(s)
Colesteatoma del Oído Medio , Colesteatoma , Masculino , Femenino , Humanos , Niño , Preescolar , Colesteatoma del Oído Medio/diagnóstico por imagen , Colesteatoma del Oído Medio/cirugía , Estudios Retrospectivos , Resultado del Tratamiento , Colesteatoma/cirugía , Oído Medio , Apófisis Mastoides/diagnóstico por imagen , Apófisis Mastoides/cirugía
5.
Minerva Med ; 102(2): 109-13, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21483397

RESUMEN

AIM: The effects of ulinastatin, urinary trypsin inhibitor, on coagulation are not fully understood. The aim of the present study was to examine the in vitro effects of ulinastatin on coagulation using modified computerised thromboelastography (ROTEM®) with InTEM®. METHODS: A venous blood sample was obtained from the antecubital vein without stasis from 12 healthy adult men. A 290 µL aliquot of blood was combined with either 10 µL of ulinastatin (100 [U100], 200 [U200] or 1000 [U1000] U/mL) or 10 µL of normal saline. The samples were analysed simultaneously at 37 ºC on a four channel ROTEM® with InTEM®. RESULTS: Clotting time was significantly increased in the U200 (155.8±9.3 s) and U 1000 (173.6±14.5 s) groups, compared with the control group (136.1±12.6 s). The U 1000 group significantly increased clot formation time (77.6±16.2 s; control group, 63.8±13.4 s) and significantly decreased α angle (74.6±3.3º; control group, 77.4±2.4º). No significant difference in maximum clot firmness or maximum lysis was found between the control and ulinastatin groups. CONCLUSION: In-vitro ulinastatin had a direct anticoagulant effects, as assessed by ROTEM® with InTEM®, and the results were within the normal ranges.


Asunto(s)
Coagulación Sanguínea/efectos de los fármacos , Glicoproteínas/farmacología , Tromboelastografía/métodos , Inhibidores de Tripsina/farmacología , Adulto , Humanos , Masculino , Valores de Referencia , Tiempo de Coagulación de la Sangre Total
6.
Ultrasound Obstet Gynecol ; 36(6): 749-54, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20205152

RESUMEN

OBJECTIVE: To evaluate whether the degree of cervical length shortening is valuable in predicting the success of serial induction of labor on the second day in women in whom it failed on the first day, and to compare its performance with that of cervical length. METHODS: This was a prospective observational study. We enrolled 92 consecutive women with singleton gestations at > 34.0 weeks' gestation who failed labor induction on the first day of serial induction. Transvaginal sonographic measurement of cervical length and determination of the Bishop score were undertaken before performing each labor induction on the first and second days. RESULTS: The overall success rate of labor induction performed on the second day was 65% (60/92). Multiple logistic regression analysis demonstrated that the degree of cervical length shortening and cervical length were significantly associated with the successful induction of labor after adjustment for body mass index, parity, use of prostaglandin and Bishop score. There were no significant differences between areas under the ROC curves for degree of cervical length shortening and cervical length. CONCLUSIONS: The degree of cervical length shortening is valuable in predicting the success of induction of labor on the second day in women in whom induction failed on the first day. However, compared with sonographic cervical length it is no better at predicting the success of subsequent induction of labor.


Asunto(s)
Cuello del Útero/diagnóstico por imagen , Trabajo de Parto Inducido , Adulto , Medición de Longitud Cervical/métodos , Cuello del Útero/anatomía & histología , Femenino , Humanos , Trabajo de Parto Inducido/métodos , Valor Predictivo de las Pruebas , Embarazo , Estudios Prospectivos , Curva ROC
7.
Ultrasound Obstet Gynecol ; 36(4): 486-92, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20586108

RESUMEN

OBJECTIVES: To identify the clinical and sonographic parameters at 37 weeks' gestation that predict the risk of Cesarean delivery in labor for nulliparas. METHODS: This prospective observational study recruited nulliparas with singleton pregnancies at 37 weeks' gestation. Determination of the Bishop score, ultrasound measurement of the cervical length, and fetal biometry were performed. The clinical parameters studied were maternal age, height and weight and Bishop score. The sonographic parameters included fetal biparietal diameter, femur length, abdominal circumference (AC), estimated fetal weight (EFW), amniotic fluid index and cervical length. RESULTS: Four hundred and fifty-three women were examined; 57 women (12.6%) underwent an emergency Cesarean delivery in labor. Logistic regression analysis identified maternal age and height and fetal AC and EFW, but not cervical length or Bishop score, as the best predictors of Cesarean delivery. Of these predictors, maternal age and height and fetal AC at 37 weeks were included in a final model for risk scoring. The model was shown to have an adequate goodness of fit (P = 0.473), and the area under the receiver-operating characteristics curve was 0.758, indicating reasonably good discrimination. CONCLUSIONS: Maternal age and height and fetal AC and EFW at 37 weeks' gestation are the most important parameters in predicting the risk of Cesarean delivery in nulliparas; sonographic measurement of the cervical length and the Bishop score were not predictive of Cesarean delivery. A predictive model using these parameters at 37 weeks provides useful information in the decision-making process regarding the mode of delivery.


Asunto(s)
Cuello del Útero/diagnóstico por imagen , Cesárea/estadística & datos numéricos , Adulto , Maduración Cervical/fisiología , Cuello del Útero/fisiopatología , Femenino , Peso Fetal/fisiología , Edad Gestacional , Humanos , Trabajo de Parto Inducido , Edad Materna , Valor Predictivo de las Pruebas , Embarazo , Estudios Prospectivos , Curva ROC , Ultrasonografía Prenatal
8.
Eur Phys J C Part Fields ; 78(6): 490, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30956554

RESUMEN

The COSINE-100 dark matter search experiment is an array of NaI(Tl) crystal detectors located in the Yangyang Underground Laboratory (Y2L). To understand measured backgrounds in the NaI(Tl) crystals we have performed Monte Carlo simulations using the Geant4 toolkit and developed background models for each crystal that consider contributions from both internal and external sources, including cosmogenic nuclides. The background models are based on comparisons of measurement data with Monte Carlo simulations that are guided by a campaign of material assays and are used to evaluate backgrounds and identify their sources. The average background level for the six crystals (70 kg total mass) that are studied is 3.5 counts/day/keV/kg in the (2-6) keV energy interval. The dominant contributors in this energy region are found to be 210 Pb and 3 H.

9.
Biochem Pharmacol ; 60(7): 1001-8, 2000 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-10974210

RESUMEN

The possibility of NQ12 (2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone) as a novel antithrombotic agent and its mode of action were investigated. The effects of NQ12 on platelet aggregation in human platelet-rich plasma in vitro, in rats ex vivo, and on murine pulmonary thrombosis in vivo, as well as the mode of antithrombotic action were examined. NQ12 potently inhibited ADP-, collagen-, epinephrine-, and calcium ionophore-induced human platelet aggregations in vitro concentration-dependently. NQ12 significantly inhibited rat platelet aggregation in an ex vivo study. NQ12 prevented murine pulmonary thrombosis in a dose-dependent manner. However, NQ12 did not affect coagulation parameters such as activated partial thromboplastin time, prothrombin time, and thrombin time. NQ12 inhibited fibrinogen binding to the platelet surface GPIIb/IIIa receptor, but failed to inhibit binding to the purified GPIIb/IIIa receptor. Thromboxane B(2) formation caused by thrombin or collagen was inhibited significantly by NQ12. The phosphoinositide breakdown induced by thrombin or collagen was inhibited concentration-dependently by NQ12. These results suggest that NQ12 may be a promising antithrombotic agent, and its antithrombotic activity may be due to antiplatelet aggregation activity, which may result from the inhibition of phosphoinositide breakdown and thromboxane A(2) formation.


Asunto(s)
Fibrinolíticos/farmacología , Naftalenos/farmacología , Inhibidores de Agregación Plaquetaria/farmacología , Agregación Plaquetaria/efectos de los fármacos , Animales , Coagulación Sanguínea/efectos de los fármacos , Plaquetas/efectos de los fármacos , Plaquetas/metabolismo , Modelos Animales de Enfermedad , Fibrinolíticos/síntesis química , Fibrinolíticos/química , Fibrinolíticos/uso terapéutico , Fosfatos de Inositol/metabolismo , Masculino , Ratones , Ratones Endogámicos ICR , Naftalenos/síntesis química , Naftalenos/química , Naftalenos/uso terapéutico , Inhibidores de Agregación Plaquetaria/síntesis química , Inhibidores de Agregación Plaquetaria/química , Inhibidores de Agregación Plaquetaria/uso terapéutico , Complejo GPIIb-IIIa de Glicoproteína Plaquetaria/efectos de los fármacos , Complejo GPIIb-IIIa de Glicoproteína Plaquetaria/metabolismo , Embolia Pulmonar/prevención & control , Ratas , Ratas Sprague-Dawley , Tromboxano B2/metabolismo
10.
Brain Res ; 905(1-2): 240-4, 2001 Jun 29.
Artículo en Inglés | MEDLINE | ID: mdl-11423101

RESUMEN

Phospholipase D (PLD) is one of the intracellular signal transduction enzymes and plays an important role in a variety of cellular functions. We investigated the expression and cellular localization of the PLD isozyme PLD1 in the rodent retina. Western blot analysis showed the presence of PLD1 at the protein level in the rat, mouse and guinea pig retinas. PLD1 immunoreactivity was localized in all Müller cells. Thus, PLD1 protein appears to be important in the functions of these cells in the rodent retina.


Asunto(s)
Neuroglía/enzimología , Fosfolipasa D/metabolismo , Retina/enzimología , Roedores/metabolismo , Animales , Expresión Génica/fisiología , Glutamato-Amoníaco Ligasa/metabolismo , Cobayas , Inmunohistoquímica , Ratones , Neuroglía/citología , Neuronas/citología , Neuronas/metabolismo , Ratas , Retina/citología , Roedores/anatomía & histología , Visión Ocular/fisiología
11.
Neurosci Lett ; 288(2): 143-6, 2000 Jul 14.
Artículo en Inglés | MEDLINE | ID: mdl-10876081

RESUMEN

To determine the presence of protein kinase C (PKC) isozymes in the septal olfactory epithelium of mice (mSOE), western blotting and immunohistochemistry were performed using antibodies against PKC isozymes. With the exception of PKC-betaI, all of the PKC isozymes were detected in the whole lysate of septal tissue layer and apparent molecular weights for each isoform were found. PKC-alpha, PKC-gamma and PKC-epsilon were detected in the olfactory glandular cells of the lamina propria, and PKC-betaI and PKC-betaII were located in the microvillar cells. Neither novel PKC nor atypical PKC was detected in olfactory glandular cells or microvillar cells, except for PKC-epsilon. PKC-lambda was localized in the mucous layer of the mSOE. Meanwhile, PKC-delta and PKC-xi were distributed in the receptor cells in the mSOE. These data demonstrate the isoform-specific expression of PKC in mSOE and suggest a role for the novel and atypical types of PKC in olfactory transduction.


Asunto(s)
Mucosa Olfatoria/enzimología , Proteína Quinasa C/metabolismo , Animales , Western Blotting , Encéfalo/enzimología , Inmunohistoquímica , Isoenzimas/biosíntesis , Isoenzimas/metabolismo , Ratones , Ratones Endogámicos ICR , Tabique Nasal/enzimología , Neuronas Aferentes/enzimología , Proteína Quinasa C/biosíntesis
12.
Thromb Res ; 96(3): 229-37, 1999 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-10588466

RESUMEN

The antithrombotic activities and mode of action of green tea catechins (GTC) and (-)-epigallocatechin gallate (EGCG), a major compound of GTC, were investigated. Effects of GTC and EGCG on the murine pulmonary thrombosis in vivo, human platelet aggregation in vitro, and ex vivo, and coagulation parameters were examined. GTC and EGCG prevented death caused by pulmonary thrombosis in mice in vivo in a dose-dependent manner. They significantly prolonged the mouse tail bleeding time of conscious mice. They inhibited adenosine diphosphate- and collagen-induced rat platelet aggregation ex vivo in a dose-dependent manner. GTC and EGCG inhibited ADP-, collagen-, epinephrine-, and calcium ionophore A23187-induced human platelet aggregation in vitro dose dependently. However, they did not change the coagulation parameters such as activated partial thromboplastin time, prothrombin time, and thrombin time using human citrated plasma. These results suggest that GTC and EGCG have the antithrombotic activities and the modes of antithrombotic action may be due to the antiplatelet activities, but not to anticoagulation activities.


Asunto(s)
Catequina/análogos & derivados , Catequina/farmacología , Fibrinolíticos/farmacología , Inhibidores de Agregación Plaquetaria/farmacología , Agregación Plaquetaria/efectos de los fármacos , Té/química , Adenosina Difosfato/antagonistas & inhibidores , Adenosina Difosfato/farmacología , Animales , Aspirina/farmacología , Tiempo de Sangría , Calcimicina/farmacología , Calcio/sangre , Colágeno/antagonistas & inhibidores , Colágeno/farmacología , Epinefrina/antagonistas & inhibidores , Epinefrina/farmacología , Humanos , Transporte Iónico/efectos de los fármacos , Ionóforos/farmacología , Masculino , Ratones , Ratones Endogámicos ICR , Inhibidores de Agregación Plaquetaria/aislamiento & purificación , Embolia Pulmonar/tratamiento farmacológico , Ratas , Ratas Sprague-Dawley
13.
J Toxicol Sci ; 23(2): 113-9, 1998 May.
Artículo en Inglés | MEDLINE | ID: mdl-9644651

RESUMEN

In this study, we examined whether the production of hydrogen peroxide by peroxisome proliferators causes oxidative DNA damage in the form of 8-oxodeoxyguanosine (8-oxodG) and hepatic injury, and whether it is related to their tumor-promoting or carcinogenic activities in female rats treated with the peroxisome proliferators clofibrate and perfluorodecanoic acid (PFDA). Clofibrate has tumor-promoting and carcinogenic activities, whereas PFDA does not. We also tested whether peroxisome proliferators directly induce mutagenic events in Salmonella typhimurium strains TA 98 and TA 1537. Rats were treated either by 5% clofibrate in diet or by an i.p. injection of corn oil containing 10 mg/kg body weight of PFDA every week for 2 or 8 weeks. 8-OxodG in liver DNA was analyzed by HPLC coupled with an electrochemical detector. Hepatic injury was evidenced by liver enlargement and by levels of serum enzymes, aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and hepatic gamma-glutamylpeptidase (gamma-GT) activity. Clofibrate and PFDA increased the activity of catalase about or less than 2-fold, whereas FAO activity was increased about 6 to 7-fold by clofibrate and about 3 to 4-fold by PFDA. Neither clofibrate nor PFDA induced mutation at any dose tested. Clofibrate significantly increased the formation of 8-oxodG, but PFDA only slightly increased. Serum AST and ALT levels, and hepatic gamma-GT activity were not significantly changed at both time points, whereas the ratio of liver/body weight was significantly increased by clofibrate and PFDA at 8 weeks. These data imply that the magnitude of the production of hydrogen peroxide-generated FAO is related to the induction of oxidative DNA damage by peroxisome proliferators, and their tumor-promoting or carcinogenic activities. However, the effect of hydrogen peroxide in hepatic injury is not clear.


Asunto(s)
Carcinógenos , Clofibrato/farmacología , Daño del ADN/fisiología , Ácidos Decanoicos/farmacología , Desoxiguanosina/análogos & derivados , Fluorocarburos/farmacología , Hígado/efectos de los fármacos , Hígado/metabolismo , Microcuerpos/efectos de los fármacos , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Desoxiguanosina/biosíntesis , Femenino , Peróxido de Hidrógeno/metabolismo , Pruebas de Mutagenicidad , Ratas , Ratas Sprague-Dawley
14.
Korean J Parasitol ; 32(2): 85-92, 1994 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8025037

RESUMEN

A seroepidemiologic observation of anti-Spirometra erinacei plerocercoid (sparganum) antibody (IgG) in serum was made in normal adult and epileptic patients in Korea from February, 1987 to September, 1990. Sera were tested by enzyme-linked immunosorbent assay (ELISA) for anti-sparganum antibody together with anti-Taenia solium metacestode, and anti-Paragonimus westermani antibodies. Sera reacted positively to sparganum antigen only were considered. Positive rate for anti-sparganum antibody in 850 normal adults was 1.9% (standardized rate by provincial population was 1.7%). In 2,667 randomly selected patients of epilepsy at 28 local centers of the Changmi Club, positive rate was 2.5% (standardized rate: 2.3%). In both normal adult and patient groups, the higher antibody rates were observed in Kangwon and Chonnam Provinces. Positive rates were 10 times higher in male than in female in normal adults and 4.5 times in male epileptic patients. The rates were elevated especially with age over 30-year. Odd ratio of the antibody was 1.32 which indicated an ambiguous etiologic factor for epilepsy.


Asunto(s)
Epilepsia/complicaciones , Esparganosis/epidemiología , Adolescente , Adulto , Animales , Niño , Preescolar , Femenino , Humanos , Lactante , Corea (Geográfico)/epidemiología , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Seroepidemiológicos , Esparganosis/complicaciones
15.
J Int Med Res ; 40(6): 2295-304, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23321186

RESUMEN

OBJECTIVE: Change in thoracic fluid content (TFC) derived via a bioreactance technique with a noninvasive cardiac output monitoring device (NICOM) reportedly shows a good correlation with the amount of fluid removed. The present study prospectively evaluated the utility and clinical application of TFC in the intraoperative fluid management of paediatric patients with congenital heart disease, undergoing cardiac surgery with bioreactance-based noninvasive monitoring. METHODS: Haemodynamic parameters, patient body weight and parameters derived from the NICOM device (including cardiac output, cardiac index, TFC, percentage change in TFC compared with baseline [TFCd0%] and stroke volume variation) were recorded after anaesthesia induction but before surgical incision, and just before departure from the operating room to the intensive care unit. RESULTS: In the 80 paediatric patients included in this study, linear regression analyses demonstrated good correlations between body weight gain and TFCd0%, between body weight gain % and TFCd0%, and between intra operative fluid balance and TFCd0%. CONCLUSION: TFCd0% may be a useful indicator for intraoperative fluid management in paediatric patients with congenital heart disease, undergoing cardiac surgery.


Asunto(s)
Líquidos Corporales , Procedimientos Quirúrgicos Cardíacos , Cardiopatías Congénitas/cirugía , Monitoreo Fisiológico/métodos , Aumento de Peso , Peso Corporal , Gasto Cardíaco , Femenino , Corazón/fisiología , Hemodinámica , Humanos , Lactante , Masculino , Monitoreo Fisiológico/instrumentación
16.
Anaesth Intensive Care ; 40(5): 773-9, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22934858

RESUMEN

We hypothesised that relaxation of the serratus anterior muscle by long thoracic nerve (LTN) block could help pain relief after video-assisted thoracoscopic surgery. Patients undergoing thoracoscopic wedge resection for pneumothorax were randomly assigned to control or LTN block. LTN block was performed before induction of general anaesthesia. Pain was evaluated using a visual analogue scale before anaesthesia induction (T0), on arrival to the post-anaesthetic care unit (PACU) (T1), every ten minutes after arrival in the PACU for 30 minutes (T2, T3 and T4) and one hour and 24 hours after discharge from the PACU (T5 and T6). Visual analogue scale scores from T1 to T5 in the block group were lower than the control group (T1: 36±11 vs 48±14 [P=0001], T2: 36±11 vs 51±15 [P<0.001], T3: 35±vs 52±15 [P<0.001], T4: 30±7 vs 45±17 [P<0.001] and T5: 26±5 vs 32±5 [P<0.001]). Total intravenous patient-controlled analgesia bolus dose (alfentanil 75 µg/ml) during PACU stay (1.6±1.2 vs 3.9±2.0 ml, P<0.001) and one hour after discharge from the PACU (0.5±0.8 vs 1.7±1.2 ml, P<0.001) in the LTN group was significantly lower than the control group. Total intravenous patient-controlled analgesia bolus dose from 1-24 hours after discharge from the PACU was similar between groups (P=0197). These findings indicate that LTN block reduced pain after video-assisted thoracoscopic surgery from end-of-surgery to one hour after discharge from the PACU.


Asunto(s)
Bloqueo Nervioso/métodos , Neumotórax/cirugía , Cirugía Torácica Asistida por Video/métodos , Toracoscopía/métodos , Adolescente , Adulto , Femenino , Humanos , Masculino , Dimensión del Dolor
17.
J Int Med Res ; 39(4): 1201-10, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21986122

RESUMEN

This prospective, randomized, double-blind study evaluated the effect of ulinastatin on postoperative blood loss and transfusion requirements of patients undergoing open-heart surgery with cardiopulmonary bypass (CPB) and aortic cross-clamping (ACC). CPB and ACC produce variable systemic inflammatory reactions that are associated with multiorgan dysfunction via leucocytes, especially polymorphonuclear neutrophils (PMNs). PMNs increase blood loss and transfusion requirements. Ulinastatin, a urinary trypsin inhibitor, inhibits PMN activity and reduces the systemic inflammatory response. Patients received either 5000 U/kg ulinastatin or the equivalent volume of normal saline (control group) before ACC. Postoperative blood loss and transfusion requirements were recorded. Duration of intubation and length of stay in the intensive care unit (ICU) were also noted. There were no statistically significant between-group differences in postoperative blood loss and transfusion requirements. Ulinastatin caused a non-significant decrease in duration of intubation. Patients who received ulinastatin had significantly shorter ICU stays than control patients.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos/efectos adversos , Puente Cardiopulmonar/efectos adversos , Glicoproteínas/uso terapéutico , Cardiopatías/cirugía , Hemorragia Posoperatoria/tratamiento farmacológico , Hemorragia Posoperatoria/etiología , Adulto , Anciano , Transfusión Sanguínea , Estudios de Casos y Controles , Método Doble Ciego , Femenino , Cardiopatías/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Neutrófilos , Pronóstico , Estudios Prospectivos , Inhibidores de Tripsina/uso terapéutico
18.
J Int Med Res ; 39(4): 1497-503, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21986153

RESUMEN

This study investigated 151 patients undergoing cardiac surgery to determine whether measurement of regional cerebral oxygen saturation (rS(c)O(2)) using near-infrared spectroscopy (NIRS) can indicate a low haematocrit after initiation of hypothermic cardiopulmonary bypass (CPB). Haematocrit, rS(c)O(2), haemoglobin level, arterial partial pressures of carbon dioxide and oxygen, systemic blood pressure, and nasopharyngeal and rectal temperatures were determined 5 min after the initial administration of heparin for CPB and 90 s after completion of the first cardioplegic solution injection. Immediately after initiation of hypothermic CPB, rS(c)O(2), haemoglobin and haematocrit values were significantly lower than those before CPB. No significant correlations were found between the change in haematocrit and changes in left, right and mean rS(c)O(2); thus, changes in rS(c)O(2) before and after initiation of hypothermic CPB did not reflect changes in haematocrit values. This indicates that NIRS cannot provide early warning of a low haematocrit immediately after initiation of hypothermic CPB in cardiac surgery.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos , Puente Cardiopulmonar , Hipotermia , Monitoreo Intraoperatorio , Espectroscopía Infrarroja Corta , Presión Sanguínea , Temperatura Corporal , Femenino , Estudios de Seguimiento , Hematócrito , Hemoglobinas/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Oximetría , Oxígeno/sangre , Pronóstico , Factores de Riesgo
19.
J Food Sci ; 74(2): H59-64, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19323752

RESUMEN

This study was performed to compare the effect of liver protection of fine saengshik (FS) and superfine saengshik (SS) and uncooked and powdered grains and vegetables, produced by the different mill technique on the acute hepatotoxicity induced by CCl(4) in mouse. As the result of particle size distribution in number, particles included under 0.955 microm dia were 7.02% and 68.92% respectively. Hematological and serological examination showed that AST (P < 0.05) and ALT (P < 0.05) of SS + CCl(4) group decreased significantly compared with those of FS + CCl(4) group. On the examination of antioxidant effect, water extract of SS showed a higher superoxide dismutase (SOD)-like activity on the condition of the HX/XOD system than that of FS (P < 0.001). Also, the glutathione peroxidase (P < 0.01) and glutathione reductase (P < 0.05) activities in liver showed a significant difference between FS + CCl(4) and SS + CCl(4) groups. On the histological observation of liver, SS + CCl(4) group showed a mild reversible hepatocytic change and infiltration of inflammatory cells around the central veins, whereas FS + CCl(4) group showed severe agglutination necrosis by CCl(4) toxicity. These results suggest that superfine saengshik significantly improves liver protection effect compared with fine saengshik; its major mechanism is supposed to be the improved antioxidant effect of saengshik by reduced size of particles.


Asunto(s)
Grano Comestible/química , Alimentos Orgánicos/análisis , Hígado/fisiología , Verduras/química , Alimentación Animal , Animales , Tetracloruro de Carbono/toxicidad , Dieta Macrobiótica , Alimentos Orgánicos/normas , Alimentos Orgánicos/toxicidad , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/metabolismo , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/patología , Masculino , Ratones , Ratones Endogámicos ICR
20.
J Korean Med Sci ; 8(2): 145-52, 1993 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8397931

RESUMEN

Prevalence survey of neurocysticercosis was made in a mixed epilepsy patients of Changmi Club in Korea. From February 1987 to July 1990, a total of 2,667 randomly selected patients at 27 local centers was tested for their serum levels of anti-Cysticercus antibody (IgG) by enzyme-linked immunosorbent assay. Positive rate of the antibody was 4.0% in the examined patients. The standardized antibody positive rate by provincial population was 3.1%. The rate was the highest in patients living in Cheju Do (8.4%). The patient age brackets of 0 approximately 9 years and over 50-year showed higher positive rates of the antibody. In 750 normal persons who checked up routine physical examination, the antibody positive rate was 2.1% (standardized rate was 1.8%). These seroepidemiological data disclosed for the first time the prevalence of cysticercosis in epileptic patients and in population.


Asunto(s)
Anticuerpos Antihelmínticos/sangre , Cisticercosis/epidemiología , Cysticercus/inmunología , Epilepsia/complicaciones , Adolescente , Adulto , Factores de Edad , Anciano , Animales , Niño , Preescolar , Cisticercosis/complicaciones , Femenino , Humanos , Lactante , Recién Nacido , Corea (Geográfico)/epidemiología , Masculino , Persona de Mediana Edad , Factores Sexuales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA